genedrive plc (AIM:GDR)
London · Delayed Price · Currency is GBP · Price in GBX 1.200
+0.125 (11.63%)
Feb 13, 2026, 5:05 PM GMT
genedrive Market Cap
genedrive has a market cap or net worth of 12.36 million as of February 13, 2026. Its market cap has increased by 4.59% in one year.
Market Cap
12.36M
Enterprise Value
11.17M
Revenue
954.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.20
Market Cap Chart
Since April 10, 2007, genedrive's market cap has increased from 11.67M to 12.36M, an increase of 5.87%. That is a compound annual growth rate of 0.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 11.07M | 22.86% |
| Dec 31, 2025 | 9.01M | -32.30% |
| Dec 31, 2024 | 13.31M | 33.76% |
| Dec 29, 2023 | 9.95M | -2.27% |
| Dec 30, 2022 | 10.18M | -74.34% |
| Dec 31, 2021 | 39.68M | 29.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.94B |
| Inspiration Healthcare Group | 15.47M |
| Oxford BioDynamics | 12.01M |
| CelLBxHealth | 11.93M |
| Verici Dx | 10.44M |